Friday, January 22, 2016 10:53:03 AM
it seems that Roche buys anything Cancer related.
Here's to Hoping...
Avant Diagnostics' OvaDx® immuno-oncology diagnostic assay is a protein-based test, potentially representing a significant improvement in the screening and diagnosis for ovarian cancer. OvaDx offers the possibility to make a clear improvement to the current diagnostic standard that generates over $2B in sales annually by substantially improving the accuracy of diagnosis, and allowing for a more effective therapeutic triaging and intervention strategy. Longer term, the assay could become a much-needed early screening tool for all women as part of a standard screening paradigm. It is estimated that the market opportunity for OvaDx is $50M annually as a diagnostic test for ovarian cancer, and this opportunity would expand to over $2B annually if it were to be approved as a generalized screening and/or monitoring tool.
Roche leads $175M investment in oncology software player Flatiron
As part of the deal, Roche has agreed to buy services from Flatiron ... player steps up its life science business development activities, using the base of cancer care data it has built in recent years as a platform for the expansion.
Roche to Buy Majority Stake in Foundation Medicine, Leader in Tumor Testing
The Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority stake in the tumor-testing company Foundation Medicine for more than $1 billion, in a deal aimed at improving both cancer treatment ... not be able to buy all of ...
Roche to buy US cancer drug group Seragon
Roche has agreed to buy Seragon Pharmaceuticals, a privately owned US biotech company, for up to $1.7bn, in a deal that shows the world’s biggest drugmaker by market capitalisation has begun loosening the purse strings on its cash pile.
Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts The deal will help the world's largest maker of cancer drugs push ahead in developing treatments ... The deal comes fast on the heels of two others. Roche said last month that it would buy Bina Technologies for an undisclosed sum and pay up to $489 …
Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts
In My Own Personal Opinion Of Course!
Long AMBS!
In My Own Personal Opinion Of Course!
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
